chr7-151632145-G-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_016203.4(PRKAG2):​c.685-7C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000374 in 1,391,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000067 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000041 ( 0 hom. )

Consequence

PRKAG2
NM_016203.4 splice_region, intron

Scores

2
Splicing: ADA: 0.001312
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.170

Publications

1 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 7-151632145-G-T is Benign according to our data. Variant chr7-151632145-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 45731.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.0000411 (51/1242180) while in subpopulation NFE AF = 0.0000514 (51/992360). AF 95% confidence interval is 0.0000397. There are 0 homozygotes in GnomAdExome4. There are 29 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High AC in GnomAdExome4 at 51 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_016203.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
NM_016203.4
MANE Select
c.685-7C>A
splice_region intron
N/ANP_057287.2
PRKAG2
NM_001407035.1
c.-46C>A
5_prime_UTR
Exon 1 of 11NP_001393964.1
PRKAG2
NM_001407036.1
c.-46C>A
5_prime_UTR
Exon 1 of 11NP_001393965.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAG2
ENST00000418337.6
TSL:1
c.-46C>A
5_prime_UTR
Exon 1 of 12ENSP00000387386.2Q9UGJ0-2
PRKAG2
ENST00000287878.9
TSL:1 MANE Select
c.685-7C>A
splice_region intron
N/AENSP00000287878.3Q9UGJ0-1
PRKAG2
ENST00000392801.6
TSL:1
c.553-7C>A
splice_region intron
N/AENSP00000376549.2Q9UGJ0-3

Frequencies

GnomAD3 genomes
AF:
0.00000668
AC:
1
AN:
149756
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000411
AC:
51
AN:
1242180
Hom.:
0
Cov.:
30
AF XY:
0.0000471
AC XY:
29
AN XY:
616254
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
25796
American (AMR)
AF:
0.00
AC:
0
AN:
30754
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19474
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
63592
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
31678
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4426
European-Non Finnish (NFE)
AF:
0.0000514
AC:
51
AN:
992360
Other (OTH)
AF:
0.00
AC:
0
AN:
47922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000668
AC:
1
AN:
149756
Hom.:
0
Cov.:
32
AF XY:
0.0000137
AC XY:
1
AN XY:
73030
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0000243
AC:
1
AN:
41186
American (AMR)
AF:
0.00
AC:
0
AN:
15084
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
9708
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67074
Other (OTH)
AF:
0.00
AC:
0
AN:
2058
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not specified (2)
-
-
1
Cardiomyopathy (1)
-
-
1
Lethal congenital glycogen storage disease of heart (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
18
DANN
Benign
0.73
PhyloP100
0.17
PromoterAI
-0.087
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.11
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs397517278; hg19: chr7-151329231; COSMIC: COSV55228643; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.